Endolimax nana is a non-flagellated intestinal protozoan commonly found in the human colon and transmitted through the fecal–oral route, often via contaminated food or water. It is one of the most frequently detected protozoa on comprehensive stool tests and is typically classified as a commensal (non-pathogenic) organism.
On the GI – Advanced Profile (US BioTek), Endolimax nana is measured to provide insight into intestinal protozoal presence and overall gut ecosystem health. While Endolimax nana does not usually cause disease on its own, elevated levels may be associated with gastrointestinal symptoms in certain individuals, especially when accompanied by gut inflammation, immune imbalance, or co-detected pathogens.
In symptomatic individuals, the presence of Endolimax nana may correlate with loose stools, bloating, abdominal discomfort, or irregular bowel habits. Its detection can also serve as a marker of fecal–oral exposure and may suggest environmental or hygiene-related factors contributing to gut microbiome disruption.
Interpretation of Endolimax nana results should always consider the broader clinical context, including symptom severity, inflammatory markers, immune status, and the presence of other bacterial or parasitic organisms. Treatment is not always required, but supportive gut care or targeted antimicrobial therapy may be considered in select cases.
A low or undetectable level of Endolimax nana is generally considered a favorable finding and suggests that this protozoan is unlikely to be contributing to gastrointestinal symptoms or gut imbalance.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.